Related Experiment Video
Updated: Jun 19, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Childhood multiple sclerosis: course and management
1Hacettepe University, Department of Pediatric Neurology, Ankara 06100, Turkey. banlar@gen.hun.edu.tr
Abstract:
Multiple sclerosis in children and adolescents carries clinical and prognostic differences from the disease in adults. Although new disease-modifying therapeutic agents which became available in recent years have improved the course and prognosis of multiple sclerosis, the indications and use of these drugs in childhood have not been evaluated systematically. In addition, studies of the complex immunopathology of the disease provide many new therapeutic possibilities to be investigated. While early treatment is preferred because immunomodulatory drugs appear more efficient in early disease, the insufficiency of the current knowledge about the safety, dosage and adverse effects of new drugs in children restrict clinicians in their decision. Collection and systematic analysis of data from multiple centers may bring clarity to the course and management of childhood multiple sclerosis.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Rheumatic Heart Disease III: Medical Management

